Author

M. Romero-Cote

Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Adriana Ortega‐HernándeziD· 1 shared Carmen Gómez‐GuerreroiD· 1 shared Cristina EspadasiD· 1 shared Dulcenombre Gómez‐GarréiD· 1 shared Isabel Herrero del Real· 1 shared Jairo Lumpuy‐CastilloiD· 1 shared Jesús EgidoiD· 1 shared José TuñóniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adriana Ortega‐HernándezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Alirocumab attenuated plaque inflammation and PCSK9-induced proinflammatory signalling in M1 macrophages independently of lipid lowering

Cristina Espadas, Manuel Soto‐Catalán, M. Romero-Cote, Maria E. Kavanagh, Isabel Herrero del Real, Adriana Ortega‐Hernández, Jairo Lumpuy‐Castillo, Dulcenombre Gómez‐Garré, Jesús Egido, José Tuñón, Carmen Gómez‐Guerrero, Oscar Lorenzo

This study shows alirocumab reduces plaque inflammation and PCSK9-induced proinflammatory signaling in M1 macrophages without affecting LDL-C levels.

Biomolecules · Mar 6, 2026Peer-reviewedBiochemistry